Back to all bills
S 3019119th CongressIn Committee
No Big Blockbuster Bailouts Act
Introduced: Oct 21, 2025
Sponsor: Sen. Welch, Peter [D-VT] (D-Vermont)
Standard Summary
Comprehensive overview in 1-2 paragraphs
This Senate bill amends Medicare drug price negotiation rules to provide higher price thresholds for orphan drugs used to treat rare diseases.
Key Points
- 1Amends Medicare Drug Price Negotiation Program for orphan drugs
- 2Increases maximum price threshold from $200M to $400M for orphan drugs
- 3Applies only to drugs with exclusive rare disease indications
- 4Defines orphan drugs per Federal Food, Drug, and Cosmetic Act
- 5Applies to price applicability years beginning 2028
- 6Referred to Senate Committee on Finance
Impact Areas
Department of Health and Human ServicesMedicare beneficiariesPharmaceutical industryRare disease patient advocacyDrug pricing policy
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025